WPI 3631 (Hydromorphone Hydrochloride Extended-Release 32 mg)
Pill with imprint WPI 3631 is White, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 32 mg. It is supplied by Actavis Pharma, Inc..
Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 32 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3631
Hydromorphone Hydrochloride Extended-Release
- Imprint:
- WPI 3631
- Strength:
- 32 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-3631
More about hydromorphone
- Hydromorphone Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 370 Reviews
- Drug class: narcotic analgesics
Consumer resources
- Hydromorphone
- Hydromorphone injection
- Hydromorphone rectal
- Hydromorphone Extended-Release Tablets
- Hydromorphone Tablets
- ... +4 more
Other brands: Dilaudid, Exalgo, Palladone, Dilaudid-HP
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
